N-(3-((6-((3,5-bis(trifluoromethyl)benzyl)amino)pyrimidin-4-yl)oxy)phenyl)-2-chloroacetamide

ID: ALA5283012

Max Phase: Preclinical

Molecular Formula: C21H15ClF6N4O2

Molecular Weight: 504.82

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(CCl)Nc1cccc(Oc2cc(NCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)ncn2)c1

Standard InChI:  InChI=1S/C21H15ClF6N4O2/c22-9-18(33)32-15-2-1-3-16(7-15)34-19-8-17(30-11-31-19)29-10-12-4-13(20(23,24)25)6-14(5-12)21(26,27)28/h1-8,11H,9-10H2,(H,32,33)(H,29,30,31)

Standard InChI Key:  SYFIOVQEHUOPSD-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 34 36  0  0  0  0  0  0  0  0999 V2000
   -3.1753    1.5568    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2064    0.7324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5069    0.2952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5383   -0.5334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2654   -0.9186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9686   -0.4792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9372    0.3493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6993   -0.8622    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8387   -0.9706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1102   -0.5832    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4107   -1.0204    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3166   -0.6310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0198   -1.0704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9958   -1.8993    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2613   -2.2843    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4418   -1.8448    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7484   -0.6790    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4480   -1.1162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1750   -0.7352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8781   -1.1746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8443   -2.0032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1138   -2.3820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4141   -1.9447    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6100   -0.7938    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6461    0.0303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3779    0.4112    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4139    1.2353    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.9464    0.4675    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8738    1.9961    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4606    1.9694    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1753    2.3820    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7330   -1.6868    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4139   -0.4496    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4139   -1.2748    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  3  2  1  0
  4  3  2  0
  4  5  1  0
  6  5  2  0
  2  7  2  0
  7  6  1  0
  8  6  1  0
  4  9  1  0
  9 10  1  0
 10 11  1  0
 12 11  2  0
 13 12  1  0
 14 13  2  0
 15 14  1  0
 16 15  2  0
 16 11  1  0
 13 17  1  0
 17 18  1  0
 19 18  1  0
 20 19  2  0
 20 21  1  0
 22 21  2  0
 18 23  2  0
 23 22  1  0
 20 24  1  0
 25 24  1  0
 25 26  1  0
 27 26  1  0
 25 28  2  0
  1 29  1  0
  1 30  1  0
  1 31  1  0
  8 32  1  0
  8 33  1  0
  8 34  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5283012

    ---

Associated Targets(Human)

MAP2K7 Tchem Dual specificity mitogen-activated protein kinase kinase 7 (1145 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 504.82Molecular Weight (Monoisotopic): 504.0788AlogP: 6.10#Rotatable Bonds: 7
Polar Surface Area: 76.14Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.08CX Basic pKa: 4.71CX LogP: 5.47CX LogD: 5.47
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.30Np Likeness Score: -1.60

References

1. Kim DR, Orr MJ, Kwong AJ, Deibler KK, Munshi HH, Bridges CS, Chen TJ, Zhang X, Lacorazza HD, Scheidt KA..  (2023)  Rational Design of Highly Potent and Selective Covalent MAP2K7 Inhibitors.,  14  (5): [PMID:37197477] [10.1021/acsmedchemlett.3c00029]
2. Patel, Snahel S and 19 more authors.  2015-10-22  Scaffold-Hopping and Structure-Based Discovery of Potent, Selective, And Brain Penetrant N-(1H-Pyrazol-3-yl)pyridin-2-amine Inhibitors of Dual Leucine Zipper Kinase (DLK, MAP3K12).  [PMID:26431428]

Source